ArticlePediatric cardiology2026
Prenatally vs. Postnatally Diagnosed Congenitally Corrected Transposition of the Great Arteries is Associated with Higher Rates of Conduction Disease, Intervention and Earlier Mortality.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Congenitally corrected transposition of the great arteries (ccTGA) with biventricular physiology is presumed to carry a favorable outcome. We aimed to explore the differences in associated diagnoses (including conduction disease), management and outcomes among prenatally vs. postnatally diagnosed ccTGA cases. Secondary objective was to examine outcomes in isolated ccTGA. An international, multicenter, retrospective cohort study was conducted in 29 tertiary hospitals (6 countries) from 1990 to 2018. Patients with a single ventricle, heterotaxy syndrome, or valvar atresia were excluded. Of 331 ccTGA patients with a median follow-up of 8.6 years [IQR: 3.5–14.1], 128 (38.7%) were diagnosed prenatally at a median gestational age of 22 weeks. As compared to the postnatal group, prenatally diagnosed patients experienced earlier cardiac conduction disorders (median age at diagnosis of conduction disorders: 0.3 versus 2.7 years, p = 0.010), earlier pacemaker implantation (median age at pacing: 6.5 years [2.5–11.6] versus 0.9 year [0.1-3.0], p < 0.001) and earlier surgical intervention (intervention-free survival rate at 3 years: 50.3% versus 34.7%, p < 0.001). The 3-year survival rate was significantly lower in patients diagnosed prenatally (91.1% versus 98.4%, p = 0.002) and the median age at death was significantly younger among patients diagnosed prenatally (0.2 versus 7.0 years, p < 0.001). In both groups, isolated ccTGA (n = 63, 19%) was associated with superior outcomes with no intervention in 46.8% and only one death. Prenatally diagnosed patients with ccTGA had earlier conduction disorders and interventions than postnatally diagnosed patients and died at a younger age. Outcomes were best in patients with isolated ccTGA.
Indexed as
Identifiers
41779175What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.